JACC. Case reports · 2026
Implantable Cardioverter-Defibrillators in Pregnant Individuals: Perinatal Management and Outcomes.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Gonzalez Nichola Bomani, McCormick Jennifer, Mehta Nidhi, Ahnert Amy, Quiñones-Rivera Joanne N
Аннотация
BACKGROUND: Evidence-based guidance for pregnancy management in patients with implantable cardioverter-defibrillators (ICDs) includes careful multidisciplinary antepartum and delivery planning.
METHODS: Case series describing outcomes of 23 pregnancies among 9 patients with arrhythmias and ICDs.
RESULTS: Among the 9 patients all 23 pregnancies were carried to term, 13 of which were managed by our cardio-obstetrics program from March 2010 to October 2025. Median delivery gestational age was 39.3 weeks. Primary cesarean delivery rate was 55.5%, with cesareans performed for obstetric indications. Three pregnancies experienced cardiac complications: antepartum ventricular tachycardia, postpartum atrial fibrillation, and postpartum heart failure. No patients experienced inappropriate firings or device complications.
CONCLUSIONS: Most patients in our case series experienced excellent perinatal and cardiac outcomes, with a maternal cardiac event rate of 13.0%. Our case series highlights the crucial role of coordinated multidisciplinary care, including antiarrhythmic therapy, fetal surveillance, labor and delivery planning, and close follow-up during the postpartum period.
METHODS: Case series describing outcomes of 23 pregnancies among 9 patients with arrhythmias and ICDs.
RESULTS: Among the 9 patients all 23 pregnancies were carried to term, 13 of which were managed by our cardio-obstetrics program from March 2010 to October 2025. Median delivery gestational age was 39.3 weeks. Primary cesarean delivery rate was 55.5%, with cesareans performed for obstetric indications. Three pregnancies experienced cardiac complications: antepartum ventricular tachycardia, postpartum atrial fibrillation, and postpartum heart failure. No patients experienced inappropriate firings or device complications.
CONCLUSIONS: Most patients in our case series experienced excellent perinatal and cardiac outcomes, with a maternal cardiac event rate of 13.0%. Our case series highlights the crucial role of coordinated multidisciplinary care, including antiarrhythmic therapy, fetal surveillance, labor and delivery planning, and close follow-up during the postpartum period.